Bacterial enzymes that trim cholesterol-like side chains
Masae Horinouchi led a study identifying enzymes and structures that remove the C17 propionyl residue in Comamonas testosteroni TA441, echoing Mycobacterium tuberculosis mechanisms.
Bacteria that break down steroids are of growing interest because similar pathways help pathogens like Mycobacterium tuberculosis survive in host environments by using the C17 side chain of cholesterol. Masae Horinouchi and colleagues focused on a group of genes in the soil bacterium Comamonas testosteroni TA441 that were suspected to do the same job. The researchers started from ORF40–44, a stretch of DNA in TA441 that had been compared to the igr operon of M. tuberculosis. Although the predicted proteins from TA441 share only low amino acid identity with their M. tuberculosis counterparts, Horinouchi’s team wanted experimental proof of their roles. To do that they disrupted each gene in ORF40–44 and tested which changes blocked the removal of the C17 propionyl residue, a critical chemical step in degrading steroids that carry a C17 side chain, such as cholic acid and cholesterol. The work set out to confirm which ORFs make the dehydrogenase, hydratase, and aldolase enzymes thought to handle this part of steroid breakdown, and to learn whether the TA441 enzymes form complexes similar to those proposed in M. tuberculosis.
The central approach was genetic disruption and functional testing of ORF40–44. By making gene-disrupted mutants, the researchers showed that ORF41/44 encode the dehydrogenase, ORF40/42 encode the hydratase, and ORF43 encodes the aldolase. ORF40 proved to be a bifunctional protein made of a MaoC domain and a DUF35 domain. The study found that the ORF40 MaoC domain together with the ORF42-encoded protein form the hydratase activity, while the DUF35 domain is essential for aldolase activity. A mutant engineered to express ORF40 MaoC and ORF40 DUF35 as separate proteins still showed both hydratase and aldolase activities, indicating these functions do not require a single, inseparable complex. At the same time, efficient propionyl residue removal appears to depend on proper formation of each enzymatic complex, including ChsE1E2, ChsH1H2 maoC, and Ltp2ChsH2 DUF35. The team noted that (ChsE1-ChsE2) 2 does not form a stable complex with (ChsH1-ChsH2 MaoC ) 2 -(Ltp2-ChsH2 DUF35 ) 2, although some interaction was suggested. AlphaFold-predicted 3D structures of the TA441 enzymes and their complexes revealed striking similarities to those of M. tuberculosis despite the low amino acid identities.
The findings matter because they pin down the enzymatic steps used to remove the propionyl residue at C17, a necessary move for breaking down steroids with C17 side chains. Comamonas testosteroni TA441 is a long-standing model for aerobic steroid degradation, and defining the roles of ORF40–44 fills a specific gap in the pathway the lab has studied for years. The discovery that the TA441 enzymes and their predicted 3D arrangements resemble those in Mycobacterium tuberculosis suggests that lessons from this environmental bacterium may transfer to understanding steroid metabolism in a human pathogen. That structural and functional conservation, even with low sequence identity, means TA441 can serve as a tractable system to study mechanisms that are hard to dissect directly in M. tuberculosis. Overall, this work provides experimental proof of which genes do the key chemistry and shows how their assemblies affect efficiency, offering new angles for research into bacterial steroid metabolism and its ecological and health-related roles.
This work clarifies a crucial step in bacterial steroid degradation and links a well-studied model organism to Mycobacterium tuberculosis biology. Insights from TA441 could guide future studies into how pathogens use host steroids and inform broader ecological and health research.
Author: Masae Horinouchi